These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 38662265)

  • 21. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review.
    Yang J; Xu R; Wang C; Qiu J; Ren B; You L
    Cancer Commun (Lond); 2021 Dec; 41(12):1257-1274. PubMed ID: 34331845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.
    Young MR; Wagner PD; Ghosh S; Rinaudo JA; Baker SG; Zaret KS; Goggins M; Srivastava S
    Pancreas; 2018 Feb; 47(2):135-141. PubMed ID: 29346214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.
    Maker AV; Carrara S; Jamieson NB; Pelaez-Luna M; Lennon AM; Dal Molin M; Scarpa A; Frulloni L; Brugge WR
    J Am Coll Surg; 2015 Feb; 220(2):243-53. PubMed ID: 25592469
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer.
    Guo J; Xie K; Zheng S
    Int J Biol Sci; 2016; 12(3):292-301. PubMed ID: 26929736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refinement of screening for familial pancreatic cancer.
    Bartsch DK; Slater EP; Carrato A; Ibrahim IS; Guillen-Ponce C; Vasen HF; Matthäi E; Earl J; Jendryschek FS; Figiel J; Steinkamp M; Ramaswamy A; Vázquez-Sequeiros E; Muñoz-Beltran M; Montans J; Mocci E; Bonsing BA; Wasser M; Klöppel G; Langer P; Fendrich V; Gress TM
    Gut; 2016 Aug; 65(8):1314-21. PubMed ID: 27222532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer.
    Ying L; Sharma A; Chhoda A; Ruzgar N; Hasan N; Kwak R; Wolfgang CL; Wang TH; Kunstman JW; Salem RR; Wood LD; Iacobuzio-Donahue C; Schneider EB; Farrell JJ; Ahuja N
    Pancreas; 2021 Oct; 50(9):1267-1273. PubMed ID: 34860810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
    Haugk B
    Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?
    Lennon AM; Wolfgang CL; Canto MI; Klein AP; Herman JM; Goggins M; Fishman EK; Kamel I; Weiss MJ; Diaz LA; Papadopoulos N; Kinzler KW; Vogelstein B; Hruban RH
    Cancer Res; 2014 Jul; 74(13):3381-9. PubMed ID: 24924775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
    Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
    Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early detection of pancreatic cancer.
    Garg SK; Chari ST
    Curr Opin Gastroenterol; 2020 Sep; 36(5):456-461. PubMed ID: 32657789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements.
    Dbouk M; Brewer Gutierrez OI; Lennon AM; Chuidian M; Shin EJ; Kamel IR; Fishman EK; He J; Burkhart RA; Wolfgang CL; Hruban RH; Goggins MG; Canto MI
    Pancreatology; 2021 Apr; 21(3):613-621. PubMed ID: 33593706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?
    Bartsch DK; Dietzel K; Bargello M; Matthaei E; Kloeppel G; Esposito I; Heverhagen JT; Gress TM; Slater EP; Langer P
    Fam Cancer; 2013 Mar; 12(1):89-96. PubMed ID: 23179793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of CA19-9 and Blood Free-Circulating Methylated RUNX3 May Be Useful to Diagnose Stage I Pancreatic Cancer.
    Fujimoto Y; Suehiro Y; Kaino S; Suenaga S; Tsuyama T; Matsui H; Higaki S; Fujii I; Suzuki C; Hoshida T; Matsumoto T; Takami T; Nagano H; Sakaida I; Yamasaki T
    Oncology; 2021; 99(4):234-239. PubMed ID: 33440396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial pancreatic cancer--status quo.
    Fendrich V; Langer P; Bartsch DK
    Int J Colorectal Dis; 2014 Feb; 29(2):139-45. PubMed ID: 23948969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy.
    Ge L; Pan B; Song F; Ma J; Zeraatkar D; Zhou J; Tian J
    BMJ Open; 2017 Dec; 7(12):e018175. PubMed ID: 29282264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
    Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
    Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
    Dittmar RL; Liu S; Tai MC; Rajapakshe K; Huang Y; Longton G; DeCapite C; Hurd MW; Paris PL; Kirkwood KS; Coarfa C; Maitra A; Brand RE; Killary AM; Sen S
    Cancer Prev Res (Phila); 2021 Jul; 14(7):729-740. PubMed ID: 33893071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.